Infant Bacterial Therapeutics AB (9IB.STU) Q2 2026 Earnings

6MayConfirmed
Q1 2026
Next
-0.13
-0.13
-0.13
-0.13

Details

Expected EPS
-0.12636848075999998
Actual EPS
N/A
Surprise EPS
0.13
Surprise Percent
+100%

Description

Infant Bacterial Therapeutics AB (9IB.STU) will report earnings of for Q2 2026 on May 06, 2026.

0 Comments

Share your thoughts